A Case of Vitiligo in a Hepatitis C Patient after Pegylated Interferon Treatment / 대한피부과학회지
Korean Journal of Dermatology
;
: 809-811, 2008.
Artículo
en Coreano
| WPRIM
| ID: wpr-94756
ABSTRACT
The use of pegylated interferon (PEG-IFN) and ribavirin is considered standard therapy for patients with chronic hepatitis C. The treatment has been linked with a number of dermatologic manifestations such as alopecia, skin rash, pruritus, injection site inflammation and occasionally, with vitiligo. We report a case of vitiligo that occurred during treatment with PEG-IFN and ribavirin in a hepatitis C patient. The autoimmune adverse effects of IFN therapy should be considered in the treatment of vitiligo in such patients.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Prurito
/
Ribavirina
/
Vitíligo
/
Interferones
/
Hepatitis C
/
Hepatitis C Crónica
/
Alopecia
/
Exantema
/
Hepatitis
/
Inflamación
Límite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Dermatology
Año:
2008
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS